Inhibition of Akt and Smad3 Signaling
Corresponding Organization :
Other organizations : University of Idaho
Variable analysis
- Treatment with 50 ng/mL recombinant human TGFβ2 (PeproTech)
- Treatment with 500 nM of the Akt inhibitor MK-2206 (MedChem Express, Monmouth Junction, NJ)
- Treatment with 2 μM of the Smad3 inhibitor SIS3 (Tocris, Bristol, UK)
- Akt signaling
- Smad3 signaling
- Cell seeding in 24-well plates
- Cell culture duration (15 min, 30 min, 60 min, 24 h, 3 d, and 7 d)
- Low-serum medium
- Water and dimethyl sulfoxide (DMSO) (vehicle controls)
- Positive controls: Cells treated with TGFβ2
- Negative controls: Cells treated with water and DMSO (vehicle)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!